ArticleJournal of molecular medicine (Berlin, Germany)2014
RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow.
Jingjing Xu et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papertrialcites it